Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 AUD | +26.98% |
|
+29.03% | -15.79% |
05-08 | Island Pharmaceuticals Reallocates Grant Funding to Dengue Fever Trial; Shares Rally 13% | MT |
04-16 | Island Pharmaceuticals Reports Positive Data from Dose Study of Dengue Medication | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.79% | 4.85M | |
+16.99% | 124B | |
+18.51% | 112B | |
+4.08% | 22.94B | |
-10.56% | 17.02B | |
-16.61% | 16.88B | |
-39.94% | 16.87B | |
+2.79% | 13.63B | |
+26.22% | 11.61B | |
+103.07% | 10.31B |
- Stock Market
- Equities
- ILA Stock
- News Island Pharmaceuticals Limited
- US FDA Places Island Pharmaceuticals' Phase 2A Clinical Trial for Dengue Treatment Under Clinical Hold